Related Experiment Videos
Inositol hexaphosphate inhibits ultraviolet B-induced signal transduction
Abstract:
Inositol hexaphosphate (InsP6) has an effective anticancer action in many experimental models in vivo and in vitro. Ultraviolet B (UVB) radiation is believed to be responsible for many of the carcinogenic effects related to sun exposure, and alteration in UVB-induced signal transduction is associated with UVB-induced carcinogenesis. Here we report the effects of InsP6 on UVB-induced signal transduction. InsP6 strongly blocked UVB-induced activator protein-1 (AP-1) and NF-kappaB transcriptional activities in a dose-dependent manner. InsP6 also suppressed UVB-induced AP-1 and nuclear factor kappaB (NF-kappaB) DNA binding activities and inhibited UVB-induced phosphorylation of extracellular signal-regulated protein kinases (Erks) and c-Jun NH2-terminal kinases (JNKs). Phosphorylation of p38 kinases was not affected. InsP6 also blocked UVB-induced phosphorylation of IkappaB-alpha, which is known to result in the inhibition of NF-kappaB transcriptional activity. InsP6 does not block UVB-induced phosphotidylinositol-3' (PI-3) kinase activity, suggesting that the inhibition of UVB-induced AP-1 and NF-kappaB activities by InsP6 is not mediated through PI-3 kinase. Because AP-1 and NF-kappaB are important nuclear transcription factors that are related to tumor promotion, our work suggests that InsP6 prevents UVB-induced carcinogenesis by inhibiting AP-1 and NF-kappaB transcription activities.
Insights
Inositol hexaphosphate (InsP6) inhibits cancer by blocking key signaling pathways activated by ultraviolet B (UVB) radiation. This natural compound prevents UVB-induced carcinogenesis by suppressing activator protein-1 (AP-1) and nuclear factor kappaB (NF-kappaB) transcription.
Area of Science:
- Oncology
- Molecular Biology
- Dermatology
Background:
- Ultraviolet B (UVB) radiation is a primary cause of skin cancer.
- UVB exposure triggers specific signal transduction pathways, including activator protein-1 (AP-1) and nuclear factor kappaB (NF-kappaB), which are crucial in carcinogenesis.
- Inositol hexaphosphate (InsP6) demonstrates anticancer properties in various models.
Purpose of the Study:
- To investigate the effects of Inositol hexaphosphate (InsP6) on UVB-induced signal transduction pathways.
- To determine if InsP6 can inhibit UVB-induced carcinogenesis by modulating key transcription factors.
Main Methods:
- Cells were exposed to UVB radiation, and the effects of InsP6 treatment were analyzed.
- Transcriptional activities of AP-1 and NF-kappaB were measured.
- DNA binding activities of AP-1 and NF-kappaB were assessed.
- Phosphorylation levels of various kinases (Erks, JNKs, p38) and IkappaB-alpha were determined.
- Phosphatidylinositol-3' (PI-3) kinase activity was measured.
Main Results:
- InsP6 significantly inhibited UVB-induced AP-1 and NF-kappaB transcriptional and DNA binding activities in a dose-dependent manner.
- InsP6 suppressed the UVB-induced phosphorylation of extracellular signal-regulated protein kinases (Erks) and c-Jun NH2-terminal kinases (JNKs), as well as IkappaB-alpha.
- The phosphorylation of p38 kinases and the activity of PI-3 kinase were not affected by InsP6 treatment.
- InsP6's inhibitory effects on AP-1 and NF-kappaB were independent of PI-3 kinase signaling.
Conclusions:
- InsP6 effectively inhibits UVB-induced activation of AP-1 and NF-kappaB, critical transcription factors in tumor promotion.
- These findings suggest that InsP6 may prevent UVB-induced carcinogenesis by interfering with these specific signaling pathways.
- InsP6 represents a potential therapeutic or preventive agent against UVB-induced skin damage and cancer.